SCHEMBL5115686

SCHEMBL5115686

COc1ccc2oc(=O)c(-c3cc4c(=O)oc5ccc(OC)cc5c4o3)c(O)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 2/20 0.57
MAOB P27338 4/20 0.56
MAPT P10636 6/20 0.49
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 7/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
POLB P06746 1/20 0.48
STAT1 P42224 1/20 0.48
HPGD P15428 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
TP53 P04637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5111346 0.88 NQO1 (0.57) NQO1MAOBMAPTKDM4EALDH1A1
SCHEMBL5125176 0.83 MAOB (0.56) NQO1MAOBMAPTKDM4EALDH1A1
SCHEMBL5118497 0.83 ESR2 (0.49) MAOBMAPTKDM4ENPC1RAB9A
SCHEMBL5111547 0.81 MAOA (0.59) NQO1MAOBMAPTKDM4EALDH1A1
SCHEMBL5114313 0.81 CA12 (0.52) NQO1MAOBESR2CSNK2A2CSNK2B
SCHEMBL5112059 0.81 NQO1 (0.55) NQO1MAOBMEN1KMT2ALMNA
SCHEMBL5112054 0.80 CSNK2A2 (0.41) NQO1MAOBKDM4EALDH1A1POLB
SCHEMBL5119115 0.80 NQO1 (0.41) NQO1MAOBKDM4ENPC1RAB9A
SCHEMBL5114480 0.78 MAOA (0.40) NQO1MAOBMAPTKDM4EHPGD
SCHEMBL11479069 0.78 MAOB (0.71) NQO1MAOBMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US claimed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US claimed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S NQO1 60/4885MAOB 322/4885MAPT 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.